Device is a combination product.Device evaluated by mfr: the complaint device was not received for analysis.The manufacturing batch record review confirmed that the device met all material, assembly and performance specifications.The investigation conclusion is anticipated procedural complication as the event is due to a known physiological effect of the procedure noted within the directions for use, and/or device labeling.(b)(4).
|
(b)(6) clinical study.It was reported that unstable angina and in-stent restenosis occurred.In (b)(6) 2013 the subject presented with stable angina (ccs classification: 2) and was referred for cardiac catheterization.Target lesion #1 was located in the proximal left anterior descending artery (lad) with 80% stenosis and was 16 mm long with a reference vessel diameter of 3.0 mm.Target lesion #1 was treated with pre-dilatation and placement of 3.00 x 20 mm study stent with 0% residual stenosis.In (b)(6) 2013, the subject was discharged on dual antiplatelet therapy.In (b)(6) 2018, 1715 the subject was admitted due to recurrent chest pain and syncope.The subject also stated that he had frequent episodes of palpitation and nausea.The subject¿s symptoms were assessed as unstable angina with ccs iii.On admission, electrocardiogram (ecg) revealed deep t wave inversion in the precordial leads (v2-v6) and these changes were new.Cardiac markers were normal.The subject was referred for coronary angiography for further evaluation.The 90% in-stent restenosis in proximal lad was treated with the placement of a 3.0 x 12 mm synergy¿ stent with 0% residual stenosis and timi 3 flow.
|